Aignosis is a startup based in Germany, most recent round Seed, 2 tracked investors.
Aignosis is a company founded in 2020 headquartered in Germany. Its most recent tracked round is Seed. Brouky records 2 investors associated with the company.
Aignosis is a medical device company developing AI-powered solutions for the early and accurate diagnosis of neurological disorders. Their initial product focuses on improving the assessment of Multiple Sclerosis progression.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.